logo

For the Inventor, By the Inventor

Ronde, Denmark

Thor Las Holtet

This inventor holds 12 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignees: Anaphore, Inc., Abbott Gmbh & Co Kg, Hoffmann-La Roche Inc.. Active years: 1999-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thor Las Holtet. Retrieved from https://idiyas.com/inventor/thor-las-holtet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 16.7

 

Average Co-Inventor Count = 8.1

ph-index = 6

Forward Citations = 478(Granted Patents)


Location History:

  • Aarhus V, DK (1999)
  • Royston, GB (2005 - 2009)
  • Rønde, DK (2010 - 2011)
  • Frederikssund, DK (2010 - 2012)
  • Ronde, DK (2014 - 2015)

Company Filing History:

goldMedal5 out of 5 
 
Anaphore, Inc.
 patents
silverMedal4 out of 140 
 
Abbott Gmbh & Co Kg
 patents
bronzeMedal3 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents
4. 1 out of 167 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
5. 1 out of 827 
 
Abbvie Inc.
 patents
6. 1 out of 2 
 
Denzyme Aps
 patents
where one patent can have more than one assignee

Years Active: 1999-2015

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same (2015-05-19),
2. 8865174 - Methods of treatment using human antibodies that bind IL-12 (2014-10-21),
3. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),
4. 8318679 - Trimerising module (2012-11-27),
5. 8192953 - Trimerising module (2012-06-05),
6. 8017559 - Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains (2011-09-13),
7. 7883704 - Methods for inhibiting the activity of the P40 subunit of human IL-12 (2011-02-08),
8. 7820622 - TNF antagonists (2010-10-26),
9. 7642044 - Trimerising module (2010-01-05),
10. 7504485 - Human antibodies that bind human IL-12 (2009-03-17),
11. 6914128 - Human antibodies that bind human IL-12 and methods for producing (2005-07-05),
12. 5917018 - Iterative method of at least five cycles for the refolding of proteins (1999-06-29),

Title: The Innovative Journey of Thor Las Holtet

Introduction: Thor Las Holtet, a visionary inventor hailing from Ronde, Denmark, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Holtet's latest patents include a cutting-edge renewable energy device that harnesses solar power more efficiently, a revolutionary medical device aimed at improving patient care, and a smart home technology system that enhances convenience and security for homeowners.

Career Highlights: With a career spanning over two decades, Holtet has established himself as a leading figure in the innovation landscape. His work has been recognized globally, earning him prestigious awards and accolades for his inventive solutions to complex problems.

Collaborations: Throughout his career, Holtet has collaborated with top research institutions, leading companies, and brilliant minds in the industry. His ability to work seamlessly in multidisciplinary teams has led to the development of groundbreaking technologies that have transformed various sectors.

Conclusion: Thor Las Holtet's relentless pursuit of innovation and his passion for creating solutions that improve lives have solidified his position as a respected inventor in the world of technology. His dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…